Free tool
Diagnostics stocks
We cover 5 companies grouped under the Diagnostics theme. The median market value in the group is $5.25M. Across the group, the median move over the past trading day is −1.38%. Price change over the past year runs from −98.9% to −18.6% across the middle 80 percent of the group, with a median of −79.2%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
5 of 150 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| CIZ.L | Cizzle Biotechnology Holdings Plc | $8.70M | Micro cap | +7.14% |
| VRCI.L | Verici Dx plc | $7.02M | Micro cap | −57.14% |
| VNRX | VolitionRx Limited | $5.25M | Micro cap | −97.21% |
| ADTX | Aditxt, Inc. | $2.59M | Micro cap | −100.00% |
| 2CUREX.ST | 2cureX AB (publ) | $1.75M | Micro cap | −79.23% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.